7 Common and Serious Side Effects of Airsupra
Meta Description: Learn about the 7 common and serious side effects of Airsupra and how to manage risks like oral thrush or heart issues through proper inhaler [...]
Read MoreMedically reviewed by Alan Lucks | MD, Alan Lucks MDPC Private Practice - New York on December 19th, 2023.
The condition stems from mutations in the GAA gene that prevent production of acid alpha-glucosidase enzyme, causing glycogen to accumulate destructively in muscle and heart tissue.
Infantile-onset cases present within months with severe cardiomyopathy and hypotonia, while late-onset typically emerges between ages 20-60 with progressive limb-girdle weakness and respiratory decline.
Diagnosis requires enzyme activity testing showing less than 1% normal levels in dried blood spots, confirmed by genetic testing revealing two pathogenic GAA variants.
Enzyme replacement therapy with alglucosidase alfa requires lifelong IV infusions every 2 weeks at 20mg/kg, though cardiac damage in infantile cases may be irreversible if treatment starts after 6 months.
The newer cipaglucosidase alfa combined with miglustat showed 40% greater improvement in walking ability compared to standard therapy in clinical trials for late-onset patients.
Pompe disease, also known as GAA deficiency or type II glycogen storage disease (GSD), is a rare genetic disorder that affects the body's ability to break down a complex sugar called glycogen for energy. When the body cannot produce enough of the protein responsible for breaking down glycogen, it accumulates in the muscles and organs, leading to various symptoms and complications.
Pompe disease is an inherited condition, meaning it is passed down from parents to their children. To develop the disease, an individual must inherit two flawed genes, one from each parent. If a person has only one flawed gene, they will not experience symptoms but can still pass the gene on to their children.
The symptoms of Pompe disease can vary greatly from person to person, depending on the age of onset and the severity of the condition. There are two main types of Pompe disease:
Symptoms usually appear between a few months old and age 1, and may include:
Trouble eating and poor weight gain
Delayed motor development (rolling over, sitting up)
Breathing problems and lung infections
Enlarged heart or heart defects
Enlarged liver and tongue
Symptoms can appear as late as adulthood, and may include:
Weakness in the legs, trunk, and arms
Shortness of breath, difficulty exercising, and lung infections
Breathing problems during sleep
Spinal curvature (scoliosis)
Enlarged liver and tongue
Stiff joints
Diagnosing Pompe disease can be challenging, as many symptoms are similar to those of other medical conditions. Your doctor may ask about your medical history, family history, and current symptoms. To confirm the diagnosis, the following tests may be performed:
Muscle biopsy to check glycogen levels
Blood test to evaluate the activity of the affected protein
Genetic testing to identify the specific gene mutation
Once a diagnosis is confirmed, it is recommended that family members also undergo genetic testing.
Early treatment is crucial for managing Pompe disease and minimizing damage to the body. The primary treatment is enzyme replacement therapy (ERT), which involves replacing the missing protein through injections. There are three FDA-approved medications for ERT:
Lumizyme
Myozyme (for babies and children)
Nexviazyme (for those 1 year of age and older with late-onset Pompe disease)
For adults with late-onset Pompe disease who have not responded well to ERT, a new combination treatment has been approved. This involves taking the injectable ERT cipaglucosidase alfa-atga (Pombiliti) along with miglustat (Opfolda), an enzyme stabilizer in capsule form.
Living with Pompe disease can be emotionally and physically challenging. Seeking support from counselors, support groups, and healthcare professionals can help individuals and families cope with the condition and make necessary lifestyle adjustments. A multidisciplinary team of specialists, including cardiologists, neurologists, respiratory therapists, and nutritionists, can provide comprehensive care and help manage symptoms.
While there is currently no cure for Pompe disease, early diagnosis and treatment can significantly improve quality of life and extend life expectancy. For more information and support, visit the Acid Maltase Deficiency Association, National Organization for Rare Disorders (NORD), or the Pompe Community website.
Early intervention with enzyme replacement therapy can significantly slow disease progression, but cardiac complications in infants become irreversible without treatment within the first 6 months of life. Genetic counseling is essential for families since each pregnancy carries a 25% recurrence risk. If you're experiencing unexplained muscle weakness or have a family history of this condition, Doctronic can connect you with specialists for proper evaluation.
Meta Description: Learn about the 7 common and serious side effects of Airsupra and how to manage risks like oral thrush or heart issues through proper inhaler [...]
Read MoreMeta Description: Learn about 8 budesonide interactions and what to avoid when you’re taking budesonide, including grapefruit and common drugs, to ensure your treatment is [...]
Read MoreMeta Description: Learn about these 7 Xolair interactions and what to avoid when you’re taking Xolair to safely manage your asthma, chronic hives, or nasal polyp [...]
Read More